amsacrine has been researched along with netropsin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailly, C; Collyn-d'Hooghe, M; Colson, P; Fosse, P; Fournier, C; Hecquet, B; Hénichart, JP; Houssier, C; Lantoine, D; Saucier, JM | 1 |
Heimpel, S; Hiller, KH; Hoehn, H; Poot, M | 1 |
Bailly, C; Bourdouxhe, C; Colson, P; Denny, WA; Hénichart, JP; Houssier, C; Waring, MJ | 1 |
Auclair, C; Carteau, S; Goulaouic, H; Mouscadet, JF; Subra, F | 1 |
Bailly, C; Bourdouxhe-Housiaux, C; Colson, P; Houssier, C; Waring, MJ | 1 |
Bailly, C; Denny, WA; Henichart, JP; Riou, JF; Waring, MJ | 1 |
Herdewijn, P; Zhang, Z | 1 |
7 other study(ies) available for amsacrine and netropsin
Article | Year |
---|---|
Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II.
Topics: Amsacrine; Animals; Body Weight; Cell Division; Chromatin; DNA Damage; Drug Design; Female; Fluorouracil; Humans; Leukemia P388; Mice; Netropsin; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
Topics: Amsacrine; Bisbenzimidazole; Camptothecin; Cell Cycle; Cell Line; Distamycins; DNA; Dose-Response Relationship, Drug; Ethidium; Flow Cytometry; Humans; Intercalating Agents; Kinetics; Lymphocytes; Netropsin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Cattle; Circular Dichroism; DNA; Drug Design; Intercalating Agents; Molecular Sequence Data; Netropsin; Oligodeoxyribonucleotides; Spectrum Analysis | 1995 |
Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Topics: Amsacrine; Antineoplastic Agents; Antiviral Agents; Base Sequence; Camptothecin; Carbazoles; DNA Nucleotidyltransferases; Ellipticines; Escherichia coli; Etoposide; HIV Long Terminal Repeat; HIV-1; Integrases; Kinetics; Molecular Sequence Data; Netropsin; Oligodeoxyribonucleotides; Plasmids; Recombinant Proteins; Substrate Specificity; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1993 |
Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Cattle; Chromatin; Circular Dichroism; DNA; DNA Adducts; Drug Design; In Vitro Techniques; Intercalating Agents; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Netropsin; Nucleic Acid Conformation | 1996 |
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
Topics: Amsacrine; Antineoplastic Agents; Base Sequence; Copper; DNA; DNA Footprinting; DNA Topoisomerases, Type II; Intercalating Agents; Molecular Sequence Data; Netropsin; Oxidation-Reduction | 1997 |
Selection of an unnatural peptide library for dsDNA binding.
Topics: Amino Acids; Amsacrine; Binding Sites; Chemistry, Pharmaceutical; Combinatorial Chemistry Techniques; DNA; Drug Design; Humans; Models, Molecular; Netropsin; Peptide Library | 2001 |